Soleno Therapeutics, Inc. (SLNO)

NASDAQ: SLNO · Real-Time Price · USD

39.49

+2.50 (6.76%)

At close: Apr 2, 2026, 4:00 PM EDT

39.60

+0.11 (0.28%)

After-hours: Apr 2, 2026, 7:59 PM EDT

Soleno Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	20.89	-175.85	-38.99	-24.07	-30.91
Depreciation & Amortization	2.02	1.99	1.96	1.96	1.96
Stock-Based Compensation	45.85	99.96	5.95	2.53	3.28
Other Adjustments	2.68	-1.21	3.22	-0.45	-0.95
Change in Receivables	-28.21	-	-	-	-
Changes in Inventories	-14.03	-	-	-	-
Changes in Accounts Payable	3.61	5.67	1.37	-1.48	-0.24
Changes in Accrued Expenses	4.9	1.64	1.46	0.75	-0.65
Changes in Other Operating Activities	9.09	-1.3	0.1	-0.03	-0.27
Operating Cash Flow	46.8	-69.1	-24.94	-20.78	-27.77
Capital Expenditures	-0.07	-0.22	-	-0.01	-0.02
Purchases of Investments	-455.78	-356.46	-	-	-
Proceeds from Sale of Investments	254.07	131	-	-	-
Investing Cash Flow	-201.78	-225.68	-	-0.01	-0.02
Long-Term Debt Issued	-	49.89	-	-	-
Net Long-Term Debt Issued (Repaid)	-	49.89	-	-	-
Issuance of Common Stock	238.11	163.14	180.02	14.11	-
Repurchase of Common Stock	-100.89	-	-	-0.02	-0.12
Net Common Stock Issued (Repurchased)	137.22	163.14	180.02	14.09	-0.12
Other Financing Activities	-0.06	-	-	-	-0.01
Financing Cash Flow	137.16	213.03	180.02	14.09	-0.13
Net Cash Flow	-17.82	-81.75	155.08	-6.7	-27.92
Free Cash Flow	46.73	-69.31	-24.94	-20.79	-27.79
FCF Margin	24.54%	-	-	-	-
Free Cash Flow Per Share	0.89	-1.73	-1.51	-2.48	-5.23
Levered Free Cash Flow	46.88	-294.03	-73.09	-22.87	-30.12
Unlevered Free Cash Flow	14.93	-179.88	-36.5	-23.2	-30.74

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q